Neuroblastoma
also
Neuroblastoma, cervical (needs
completion)
- Median Age of diagnosis is…
- 22-24 months
- 35% are <1 yo
- 50% < 2yo
- 90% < 8yo
- 97% <10yo
- Most common extra-cranial solid tumor
- Most common tumor in children <1yo
Location
- 70% Abdomen (ADRENALS or retroperitoneal in sympathetic chain) ; The
primary site of neuroblastoma most
commonly is the adrenal gland.
- Nontender, firm, fixed, nodular abdominal mass; may be midline
(unlike Wilm's tumor, which is smooth, and only occasionally cross
midline)
- Calcifications in 50% (vs Wilms, which usually does not calcify)
- Other
primary sites, in order of decreasing frequency, are the
paravertebral retroperitoneum,
posterior mediastinum, pelvis, and cervical area.
- The
presenting abdominal mass also may represent hepatic metastases, which can be
massive.
-
Metastatic disease may be noted
in several other sites, including skin, bone marrow, bone, and periorbital
tissue.
-
Horner syndrome can be a
complication of high thoracic and cervical masses.
-
Adrenocortical carcinomas involve the adrenal gland, but they are much less
common than neuroblastomas.
Clinical Presentation
- The family
often identifies the mass, and such a complaint never should be ignored. With the
occasional exception of a child who has constipation, this finding is almost
always a true mass.
- These
children often appear chronically ill.
- Often have severe bone pain out of proportion to physical exam
- 70% metastatic at diagnosis
- Bone, bone marrow, liver, orbit, skin
- NOT to lungs or brain (sites of high oxygen)
- Raccoon Eyes due to bleeding of orbital metastases
-
Approximately 90% to 95% of neuroblastomas produce increased catecholamines,
which can be measured by their urinary metabolites. 95% have
elevated urinary HVA or VMA
-
Urinary vanillylmandelic acid (VMA)
and homovanillic acid (HVA) are measured and compared to the excretion
of creatinine in the sample. This allows
the use of a "spot" sample and avoids the need for timed 24-hour collections
that are very difficult to obtain.
- Weight loss, Jitteriness, Flushing, Sleep Disturbance; Hypertension and
Tachycardia
- Secretory Diarrhea; Vasoactive intestinal peptide
- Fevers
- Opsoclonus/Myoclonus
- Rare paraneoplastic syndrome
- Chaotic eye movements, myoclonus & ataxia
- “Dancing eyes and dancing feet”
- Favorable biologic features and are likely to survive
- Associated with pervasive and permanent neurologic and cognitive
deficits
- May be due to an autoimmune reaction
- Antineuronal antibodies cross-react with neural brain cells to
cause acute cerebellar encephalopathy
- Steroids, IVIG or ACTH are thought to be effective
Presenting Syndromes Associated With Neuroblastoma
- Pepper syndrome: massive involvement of the liver with metastatic
disease with or without respiratory distress
- Horner's syndrome: unilateral ptosis, myosis, and anhidrosis
associated with a thoracic primary tumor. Symptoms do not recover with
tumor removal.
- Hutchinson's syndrome: limping and irritability in the young child
associated with bone and bone marrow metastases
- Opsomyoclonus: myoclonic jerking and random eye movement with or
without cerebellar ataxia. May be associated with a differentiated, favorable
outlook tumor, but sx may not resolve after tumor removal.
- Kerner-Morrison syndrome: intractable secretory diarrhea associated
with a biologically favorable tumor that secretes vasointestinal peptides. Sx
always resolve with tumor removal.
- "Racoon Eyes": Noted where there is periorbital hemorrhage
secondary to metastatic tumor.
Further Evaluation
- A thorough evaluation for metastatic disease should be performed prior to
therapy:
- Bilateral bone marrow
- MIBG scan, regular bone scan
- CT scan chest, abdomen, pelvis
- Biopsy tumor or suspicious lymph nodes
- LP not needed as CNS metastasis at diagnosis is rare
Staging: International Neuroblastoma Staging System (INSS)
- Stage 1: localized tumor with complete gross excision; confined to organ
- Stage 2: localized tumor with incomplete gross excision; extends beyond
organ but not beyond midline
- 2A no ipsilateral lymph node involvement
- 2B with ipsilateral lymph node involvement
- Stage 3: extends beyond midline
- Stage 4: metastatic
- Stage 4S:
- Age < 1yo
- Localized primary tumor at stage 1 or 2
- Dissemination limited to the liver, skin or bone marrow
Prognosis
Poor prognostic factors
- N-myc gene amplification
- Chromosome 1p deletion and gain of long arm of chromosome 17 q
- Diploid DNA (almost like ALL, where hypodiploidy is a high-risk feature)
- Age > 1 year
- Unfavorable Shimada Pathology
Good prognostic factors
- Localized disease
- Hyperdiploid DNA (a protective factor also in ALL, standard risk)
- Age <1 year
- Favorable Shimada Pathology
Treatment
- Stages I-IV
- Excision +/-chemotherapy +/- radiation based on stage
- Stage 4S
- Treatment is controversial
- Observation: May not require therapy
Survival
- Stage 1 or 2: 75-95%
- Stage 4 & older than 1yo: 25%
- < 1 y/o: 75% survive
- >1 y/o: 30% will survive
Questions:
- What are the two strongest predictors of outcome?
- Median Age at dx?
- Present well or sick?
- n-Myc amplification: poor or favorable px?
Answers
- Age and stage at time of dx
- 2 y/o
- sick
- poor
Neuroblastoma vs Wilms
- Presentation: NB- sicker, Wilms - incidental
mass
- Age: NB younger (2 yo); Wilms older (3 yo)
- metastases: NB - Bone, BM, liver, orbit,
skin, NOT lungs or brain; Wilms: Bone, Liver,
lungs, brain
| Tumor |
Age of Presentation (years) |
Met sites |
| Hepatoblastoma |
1 |
lymph nodes |
| Neuroblastoma |
2 |
bone, BM, liver |
| Wilm's Tumor |
3 |
lungs, liver |
| Rhabdomyosarcoma |
1-5 |
LN, lungs, BM, Bones |
CHLA Board Review 2005
Abdominal masses